EFPIA statement on European Council decision on membership applications from Ukraine and Moldova

EFPIA welcomes the launch of the EU NCDs Initiative

The EU NCDs Initiative shows renewed political attention to NCDs and delivers a broad, integrated policy response across the main NCDs.

EFPIA statement on the establishment of the HTA Coordination Group

Europe has a unique opportunity to enact real step change in how it can attract and bring innovation to patients

EFPIA statement on European Council decision on membership applications from Ukraine and Moldova

EFPIA welcomes the launch of the EU NCDs Initiative

The EU NCDs Initiative shows renewed political attention to NCDs and delivers a broad, integrated policy response across the main NCDs.

EFPIA statement on the establishment of the HTA Coordination Group

Europe has a unique opportunity to enact real step change in how it can attract and bring innovation to patients

EFPIA and Vaccines Europe are deeply disappointed about the decision taken by World Trade Organization...

The decision is a serious retrograde step in our collective ability to tackle the COVID-19 pandemic and future global health threats.

EFPIA-EURORDIS Joint statement on Patient Access to Medicines for Rare Diseases

EFPIA and EURORDIS share the goal of faster, more equitable access to medicines for patients living with rare disease across Europe. Both the structured...

Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference...

An IP waiver does not address inequitable access to COVID-19 vaccines and will put global health security at risk.

EFPIA statement on the concerning impact of the In Vitro Diagnostic Regulation

Clinical trials in Europe might be reduced and access to novel therapies for patients delayed

EFPIA & Vaccines Europe’s considerations on the lessons learned from the COVID-19 pandemic

Since the onset of the COVID-19 pandemic, the research-based pharmaceutical industry has been committed to working collaboratively across the research...

EFPIA statement on the legislative proposal on the European Health Data Space (EHDS)

Removing the barriers to health data for scientific research will mean patients can benefit from the discovery of innovative treatments, medical devices...

EFPIA statement on the EU-Turkey WTO Case on Pharmaceuticals

EFPIA Members stand ready to work closely with the Government of Turkey with a view to continue to build an ecosystem enabling innovative medicines to...

Industry Pioneers the Contribution of Substance Data to decrease animal testing

A new initiative will make available previously unpublished data on chemicals tested to develop medicines.

Joint Industry Statement on the War in Ukraine

We are united in our mission of providing treatments and vaccines to all those affected by the war, wherever they are. Safe passage of medical products...